News

Bavarian Nordic Receives Marketing Authorization For Chikungunya Vaccine For Persons Aged 12 And Older In The United Kingdom
COPENHAGEN, Denmark, May 2, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization in the ...